scholarly journals Inhibition of hepatitis C virus by an M1GS ribozyme derived from the catalytic RNA subunit of Escherichia coli RNase P

2014 ◽  
Vol 11 (1) ◽  
pp. 86 ◽  
Author(s):  
Xinliang Mao ◽  
Xifang Li ◽  
Xinjun Mao ◽  
Zhiwen Huang ◽  
Chengcheng Zhang ◽  
...  
2001 ◽  
Vol 58 (3) ◽  
pp. 221-228 ◽  
Author(s):  
S. Dueñas-Carrera ◽  
A. Viña ◽  
H.E. Garay ◽  
O. Reyes ◽  
L. Alvarez-Lajonchere ◽  
...  

Apmis ◽  
2020 ◽  
Vol 128 (11) ◽  
pp. 593-602
Author(s):  
Sara Mohammadzadeh ◽  
Farzin Roohvand ◽  
Parastoo Ehsani ◽  
Ali Hatef Salmanian ◽  
Soheila Ajdary

2015 ◽  
Vol 60 (2) ◽  
pp. 925-935 ◽  
Author(s):  
Ascensión Ariza-Mateos ◽  
Rosa Díaz-Toledano ◽  
Timothy M. Block ◽  
Samuel Prieto-Vega ◽  
Alex Birk ◽  
...  

ABSTRACTThe aminoglycoside Geneticin (G418) is known to inhibit cell culture proliferation, via virus-specific mechanisms, of two different virus genera from the familyFlaviviridae. Here, we tried to determine whether Geneticin can selectively alter the switching of the nucleotide 1 to 570 RNA region of hepatitis C virus (HCV) and, if so, whether this inhibits viral growth. Two structure-dependent RNases known to specifically cleave HCV RNA were tested in the presence or absence of the drug. One was theSynechocystissp. RNase P ribozyme, which cleaves the tRNA-like domain around the AUG start codon under high-salt buffer conditions; the second wasEscherichia coliRNase III, which recognizes a double-helical RNA switch element that changes the internal ribosome entry site (IRES) from a closed (C) conformation to an open (O) one. While the drug did not affect RNase P activity, it did inhibit RNase III in the micromolar range. Kinetic studies indicated that the drug favors the switch from the C to the O conformation of the IRES by stabilizing the distal double-stranded element and inhibiting further processing of the O form. We demonstrate that, because the RNA in this region is highly conserved and essential for virus survival, Geneticin inhibits HCV Jc1 NS3 expression, the release of the viral genomic RNA, and the propagation of HCV in Huh 7.5 cells. Our study highlights the crucial role of riboswitches in HCV replication and suggests the therapeutic potential of viral-RNA-targeted antivirals.


2004 ◽  
Vol 37 (1) ◽  
pp. 144-153 ◽  
Author(s):  
Luyun Huang ◽  
Elena V Sineva ◽  
Michele R.S Hargittai ◽  
Suresh D Sharma ◽  
Mehul Suthar ◽  
...  

2008 ◽  
Vol 8 (3) ◽  
pp. 374-377 ◽  
Author(s):  
Munpally Shesheer Kumar ◽  
Khareedu Venkateswara Rao ◽  
Chittor Mohammed Habeebullah ◽  
Vudem Dashavantha Reddy

2000 ◽  
Vol 32 (2) ◽  
pp. 137 ◽  
Author(s):  
Lázaro J. Lorenzo ◽  
Odalys García ◽  
Nelson Acosta-Rivero ◽  
Santiago Dueñas-Carrera ◽  
Gillian Martínez ◽  
...  

RNA ◽  
1999 ◽  
Vol 5 (8) ◽  
pp. 1021-1033 ◽  
Author(s):  
DANIEL A. POMERANZ KRUMMEL ◽  
SIDNEY ALTMAN

Sign in / Sign up

Export Citation Format

Share Document